ASSESSMENT OF DRUG USAGE PATTERN IN PATIENTS OF ASTHMA: A CROSSSECTIONAL STUDY IN A TERTIARY CARE TEACHING HOSPITAL IN EASTERN INDIA

Author:

Samajdar Shambo Samrat1,Mitra Ritabrata2,Sutradhar Manotosh3,Ghosh Debasish4,Pal Mrinal5,Jana Debarshi6,Sengupta Amitabha7,Tripathi Shantanu8

Affiliation:

1. DM Resident in Clinical Pharmacology, Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata.

2. Assistant Professor, Department of Respiratory Medicine, IPGME&R, Kolkata.

3. Assistant Professor, Department of Critical Care Medicine, IPGME&R, Kolkata.

4. Assistant Professor, Institute Of Otorhinolaryngology And Head & Neck Surgery, IPGME&R, Kolkata.

5. Assistant Professor, Department of Biochemistry, Burdwan Medical College and Hospital

6. Young scientist, IPGME&R, Kolkata.

7. HOD, Department of Pulmonary Medicine, IPGME&R, Kolkata

8. HOD, Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, Kolkata.

Abstract

Background: In India, asthma imposes a substantial burden; though the disease still remains under-recognized, underestimated and under-treated in masses.With a global need of promoting rational drug use in healthcare, drug utilization pattern studies could provide feedback to prescribers and help in fostering rational drug usage. The present study was planned to study the drug utilization pattern in patients of asthma in a tertiary care set-up in eastern India and to evaluate it with respect to GINA guidelines. Materials and Methods: The study was carried out over a period of one year where cases with confirmed diagnosis of asthma, who gave informed consent to participate were included.Drug usage pattern was determined in the light of drugs prescribed, mean drugs per prescription, percentage of drugs prescribed in generic name and having conformation to national essential drug list. Percentage of inhalational, injectable, fixed dose combination and antibiotics per prescription were noted. Data were checked for completeness and statistically analysed. Results: The present study included 370 participants. A total of 1514 drugs were prescribed, with 4.09 drugs per prescription. 12.55% of drugs prescribed were from national essential drug list. A total of 1031 anti-asthma drugs were prescribed with 2.8 anti-asthma drugs per prescription. Among the various classes of anti-asthma drugs, maximum prescribed were inhalational corticosteroids, followed by long acting inhalational beta 2 agonist and anti-leukotriene drugs. 96.5% of total patients were on inhalational drugs, with budesonide and formeterol being majorly prescribed. Conclusion: The usage pattern as assessed in our study was in conformation to GINA guidelines. Guidelines like GINA have enlightened physicians about the rational prescribing in asthmatic patients.

Publisher

World Wide Journals

Reference16 articles.

1. 1. World Health Organization. Information on Asthma. Accessed from https://www.who.int/news-room/q-a-detail/asthma . Accessed on April 21, 2020

2. 2. Global Initiative for Asthma. A Pocket Guide for Health Professionals Updated 2019. Accessed from https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf . Accessed on April 21, 2020

3. 3. Storms WW. Unmet needs in the treatment of allergic asthma: potential role of novel biologic therapies. J Manag Care Pharm. 2003;9:534-43

4. 4. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report. 2008;(7):1–38.

5. 5. National List of essential Medicines (NLEM 2015). Accessed from http://cdsco.nic.in/WriteReadData/NLEM-2015/NLEM,%202015.pdf. Accessed on April 21, 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3